ARTIFICIAL INTELLIGENCE,

DESIGNED SPECIFICALLY FOR DRUG DISCOVERY

 

ANSWERING QUESTIONS ACROSS THE ENTIRE DEVELOPMENT PROCESS

From identifying new targets to optimizing compounds for toxicity or efficacy, we've built our platform to address multiple areas of R&D. We've built in over 10 different features into the platform and we're constantly looking to add in more.

 
 
 

Integrating Diverse Data Types For Better Predictions

Each type of data provides a different piece of the puzzle, yet most available computational methods only use or are optimized for 1 or 2 data sources. We've built our platform to integrate between 10-20 distinct types of chemical, biological clinical data for each task, and our analyses show this can lead to over a 20% increase in accuracy.

 

WHAT WE DO

Microscope.png

Target Identification

 
Bullseye.png

Candidate and Combination Discovery

 
Puzzle.png

Mechanism Deconvolution and Optimization

 
Drug.png

Repositioning and Biomarker Selection


PARTNERS AND COLLABORATORS

 

“OneThree’s AI platform helped answer direct mechanistic questions on our top drug candidates, opened up new therapeutic opportunities, helped solve problems that we had been working on for years, and potentially saved several years of additional work.

I expect that the approach OneThree Biotech is taking will be integral to the future of drug discovery and development.”

- Josh Allen, PhD, Senior Vice President: Research and Development